About Gulf Coast Consortia
The GCC delivers important advances in bioscience research and training by empowering individuals to go beyond the limitations of any single institution, discipline or degree program.
Head Office

6500 Main St., Suite 160
Houston, Texas 77030

logologo
  • Highlights
  • Research
    • Funding Opportunities
    • Antimicrobial Resistance
    • Cellular and Molecular Biophysics
    • Drug Discovery and Development
    • Junior Faculty Resource
    • Mental Health Research
    • NanoX
    • Regenerative Medicine
    • Rigor and Reproducibility Resource
    • Single Cell Omics
    • Theoretical and Computational Neuroscience
    • Translational Imaging
    • Translational Pain Research
  • Training
    • Biomedical Informatics and Data Science (NLM)
    • Computational Cancer Biology Training Program (CCBTP)
    • Molecular Biophysics Training Program (HAMBP)
    • Interdisciplinary Pharmacology Scientists (TIPS)
    • Precision Environmental Health Sciences (TPEHS)
    • Antimicrobial Resistance (TPAMR)
    • Rigor and Reproducibility Resources
    • Keck Seminar
  • Events
  • Shared Cores
  • About Us
  • Contact Us
    • GCC Job Board
  • Highlights
  • Research
    • Funding Opportunities
    • Antimicrobial Resistance
    • Cellular and Molecular Biophysics
    • Drug Discovery and Development
    • Junior Faculty Resource
    • Mental Health Research
    • NanoX
    • Regenerative Medicine
    • Rigor and Reproducibility Resource
    • Single Cell Omics
    • Theoretical and Computational Neuroscience
    • Translational Imaging
    • Translational Pain Research
  • Training
    • Biomedical Informatics and Data Science (NLM)
    • Computational Cancer Biology Training Program (CCBTP)
    • Molecular Biophysics Training Program (HAMBP)
    • Interdisciplinary Pharmacology Scientists (TIPS)
    • Precision Environmental Health Sciences (TPEHS)
    • Antimicrobial Resistance (TPAMR)
    • Rigor and Reproducibility Resources
    • Keck Seminar
  • Events
  • Shared Cores
  • About Us
  • Contact Us
    • GCC Job Board

Newsfeed

Home Home Research Consortia Antimicrobial Resistance Newsfeed
  • LBT Innovations (ASX:LBT) pockets $830K R&D rebate
    … LBT is currently developing its new Automated Plate Assessment System Antimicrobial Resistance analysis module, which is regarded as the only …
  • Alterity Therapeutics Ltd (ATHE) CEO David Stamler on Q2 2021 Results – Earnings Call Transcript
    A further question submitted was that it was good to see new application for PBT2 in treating antibiotic-resistant infections. Do you have any other …
  • Microbes could predict fatal outcomes in ventilated COVID-19 patients
    The study "Microbial signatures in the lower airways of mechanically ventilated … as well as expressing antimicrobial resistance genes and signaling.
  • Artificial sweeteners may promote antibiotic resistance
    Artificial sweeteners may promote antibiotic resistance. A man adds artificial sweetener tablets to a mug of tea. 26 February 2021.
  • Stewardship / Resistance Scan for Feb 25, 2021
    … antimicrobial resistance (AMR). The report from LHSTM's Fresh Approaches to the Study of Antimicrobials in Society project examines antibiotic use …
  • Antimicrobial Resistance
  • Membership
  • Newsfeed
  • Events
  • Resources
clients-logo
clients-logo
clients-logo
clients-logo
clients-logo
clients-logo
clients-logo
Ⓒ 2018 Gulf Coast Consortia